- Home
- RPRX vs FTS Comparison
RPRX vs FTS Comparison
Compare RPRX & FTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | FTS |
|---|---|---|
| Founded | 1996 | 1885 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 29.5B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RPRX | FTS |
|---|---|---|
| Price | $57.41 | $52.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 15 |
| Target Price | ★ $65.13 | $55.00 |
| AVG Volume (30 Days) | ★ 2.7M | 577.4K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | 1.61% | ★ 3.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $47.32 | $8.93 |
| Revenue Next Year | $8.70 | $5.85 |
| P/E Ratio | $82.08 | ★ $22.72 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $35.23 | $49.60 |
| 52 Week High | $64.38 | $59.40 |
Technical Indicators
Market Signals| Indicator | RPRX | FTS |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 28.91 |
| Support Level | $57.75 | $52.16 |
| Resistance Level | $58.84 | $58.05 |
| Average True Range (ATR) | 1.07 | 0.58 |
| MACD | -0.12 | -0.07 |
| Stochastic Oscillator | 24.51 | 0.00 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving 3.5 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.